Sanofi SA banner

Intrinsic Value

The intrinsic value of Sanofi SA (SNW) under the Base Case is EUR per share. Compared with the current market price of 86.56 EUR, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

SNW Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when SNW is below its intrinsic value
Today Hidden ·
SNW Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to SNW

Fundamental Analysis

What Sanofi Does

Pharmaceuticals Health Care

Sanofi is a global healthcare company that discovers, develops, makes, and sells prescription medicines and vaccines. Its main products cover areas like immunology, rare diseases, neurology, diabetes, and infectious diseases, along with preventive vaccines used by doctors, hospitals, public health systems, and pharmacies.

Headquarters
France FR
Employees
74 846
IPO date
Jul 1, 2002
Read the full company overview
View Company Overview

Sanofi has no economic moat

No Moat Narrow Wide

Patent protection keeps copies of some Sanofi medicines out, but it does not prevent rivals from developing alternative treatments. Competition against older medicines shows that these product-level protections do not provide a lasting shield across the company.

Read the full moat analysis
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

Sanofi insiders rarely trade

Insider trading · Last trade on Jun 6, 2026

Sold €0 Nobody sold
Bought €12.2k 2 insiders
Trades by date
Open insider trading

Continue SNW Research

Decided on Sanofi? Get an email when SNW reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one SNW stock?

The intrinsic value for Sanofi SA (SNW) under the Base Case is EUR.

Is SNW stock undervalued or overvalued?

Compared with the current market price of 86.56 EUR, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top